Cargando…
Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
PURPOSE: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a serious medical condition with a high short-term mortality rate, making accurate prognostic assessment essential for informed clinical decision-making. In this study, we aimed to develop a simple and effective prognost...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162102/ https://www.ncbi.nlm.nih.gov/pubmed/37152403 http://dx.doi.org/10.2147/IDR.S402585 |
_version_ | 1785037630872748032 |
---|---|
author | Zhang, Hao Yang, Kai Wang, Qin Jin, Lei Wang, Ling-Mei Fan, Xing-Yu Wang, Xiu Zhou, Qiang Xu, Yuan-Hong |
author_facet | Zhang, Hao Yang, Kai Wang, Qin Jin, Lei Wang, Ling-Mei Fan, Xing-Yu Wang, Xiu Zhou, Qiang Xu, Yuan-Hong |
author_sort | Zhang, Hao |
collection | PubMed |
description | PURPOSE: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a serious medical condition with a high short-term mortality rate, making accurate prognostic assessment essential for informed clinical decision-making. In this study, we aimed to develop a simple and effective prognostic model for predicting short-term mortality in patients with HBV-ACLF. PATIENTS AND METHODS: To achieve our objective, we enrolled both a cross-sectional cohort (n = 291) and a retrospective cohort (n = 185) in this study. We collected laboratory and clinical data from these cohorts and performed univariate and multivariate logistic regression analyses to identify independent predictors of short-term mortality. Subsequently, we developed a novel prognostic score for HBV-ACLF, which was validated and assessed using receiver operating characteristic (ROC) curve analysis to determine its performance. RESULTS: Our analysis revealed that the admission prealbumin (PAB) level was a robust independent predictor of 30-day mortality, with an area under the receiver operating characteristic (AUROC) of 0.760. Moreover, we developed the HIAPP score, a prognostic-score model based on PAB. The HIAPP score was significantly lower in survivors compared to non-survivors (−2.80±0.21 vs 0.97±0.41, P < 0.001). The HIAPP score’s AUROC value was 0.899, which was found to be superior to the MELD score (AUROC = 0.795) and the CLIF-C ACLF score (AUC =0.781) and comparable to the COSSH-ACLF II score (AUC =0.825) for predicting 30-day mortality. These findings were also validated in a separate cohort, further supporting the utility of the HIAPP score as a prognostic tool for HBV-ACLF patients. CONCLUSION: Our study identifies the admission PAB level as a simple and valuable predictive index for 30-day mortality in HBV-ACLF patients. Furthermore, the HIAPP score, which incorporates PAB, PLT, INR, HE, and age, is an easy-to-use and pragmatic prognostic score in predicting short-term mortality. |
format | Online Article Text |
id | pubmed-10162102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-101621022023-05-06 Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure Zhang, Hao Yang, Kai Wang, Qin Jin, Lei Wang, Ling-Mei Fan, Xing-Yu Wang, Xiu Zhou, Qiang Xu, Yuan-Hong Infect Drug Resist Original Research PURPOSE: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a serious medical condition with a high short-term mortality rate, making accurate prognostic assessment essential for informed clinical decision-making. In this study, we aimed to develop a simple and effective prognostic model for predicting short-term mortality in patients with HBV-ACLF. PATIENTS AND METHODS: To achieve our objective, we enrolled both a cross-sectional cohort (n = 291) and a retrospective cohort (n = 185) in this study. We collected laboratory and clinical data from these cohorts and performed univariate and multivariate logistic regression analyses to identify independent predictors of short-term mortality. Subsequently, we developed a novel prognostic score for HBV-ACLF, which was validated and assessed using receiver operating characteristic (ROC) curve analysis to determine its performance. RESULTS: Our analysis revealed that the admission prealbumin (PAB) level was a robust independent predictor of 30-day mortality, with an area under the receiver operating characteristic (AUROC) of 0.760. Moreover, we developed the HIAPP score, a prognostic-score model based on PAB. The HIAPP score was significantly lower in survivors compared to non-survivors (−2.80±0.21 vs 0.97±0.41, P < 0.001). The HIAPP score’s AUROC value was 0.899, which was found to be superior to the MELD score (AUROC = 0.795) and the CLIF-C ACLF score (AUC =0.781) and comparable to the COSSH-ACLF II score (AUC =0.825) for predicting 30-day mortality. These findings were also validated in a separate cohort, further supporting the utility of the HIAPP score as a prognostic tool for HBV-ACLF patients. CONCLUSION: Our study identifies the admission PAB level as a simple and valuable predictive index for 30-day mortality in HBV-ACLF patients. Furthermore, the HIAPP score, which incorporates PAB, PLT, INR, HE, and age, is an easy-to-use and pragmatic prognostic score in predicting short-term mortality. Dove 2023-05-01 /pmc/articles/PMC10162102/ /pubmed/37152403 http://dx.doi.org/10.2147/IDR.S402585 Text en © 2023 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Hao Yang, Kai Wang, Qin Jin, Lei Wang, Ling-Mei Fan, Xing-Yu Wang, Xiu Zhou, Qiang Xu, Yuan-Hong Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure |
title | Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure |
title_full | Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure |
title_fullStr | Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure |
title_full_unstemmed | Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure |
title_short | Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure |
title_sort | prealbumin as a predictor of short-term prognosis in patients with hbv-related acute-on-chronic liver failure |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162102/ https://www.ncbi.nlm.nih.gov/pubmed/37152403 http://dx.doi.org/10.2147/IDR.S402585 |
work_keys_str_mv | AT zhanghao prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure AT yangkai prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure AT wangqin prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure AT jinlei prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure AT wanglingmei prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure AT fanxingyu prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure AT wangxiu prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure AT zhouqiang prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure AT xuyuanhong prealbuminasapredictorofshorttermprognosisinpatientswithhbvrelatedacuteonchronicliverfailure |